Clinical Trial Update: An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) [Phase 3]

View source ↗

Summary

This completed Phase 3 open-label trial evaluated lipid-lowering effects of Niacin ER combined with Simvastatin versus Atorvastatin in adults with hyperlipidemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• Niacin ER (niacin extended-release)
• SIMVASTATIN (SIMVASTATIN)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Abbott | Conditions: Hyperlipidemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2009-05-13